Skip to content

APOTHEEK VAN DER PLAS: what changed

What changed

APOTHEEK VAN DER PLAS

BE 0883.632.782
NACE 47.730, Retail sale of pharmaceutical products
filed annual accounts (NBB)
Financial years compared with
Net result for the year
€3,773
2024 · €496+€3,278
Equity
€127,728
2024 · €123,954+€3,773
Cash
€42,687
2024 · €38,510+€4,177
Balance sheet total
€176,800
2024 · €196,687-€19,887

Largest movements

2024 to 2025
Assets
  • Receivables within one year -€14,360

    down €14,360 (-37.9%), from €37,933 to €23,573

    of which Trade receivables: -€13,496

  • Tangible fixed assets -€12,185

    down €12,185 (-20.0%), from €60,917 to €48,733

    of which Furniture and vehicles: -€12,785

  • Stocks and contracts +€6,126

    up €6,126 (+11.6%), from €53,031 to €59,158

  • Cash +€4,177

    up €4,177 (+10.8%), from €38,510 to €42,687

    mainly Receivables within one year (+€14,360) and Depreciation (+€14,030)

  • Deferred charges and accrued income -€3,646

    down €3,646 (-57.9%), from €6,295 to €2,649

Equity and liabilities
  • Other debts -€12,731

    down €12,731 (-72.7%), from €17,510 to €4,779

  • Trade debts -€10,986

    down €10,986 (-21.2%), from €51,749 to €40,762

  • Reserves +€3,773

    up €3,773 (+16.9%), from €22,339 to €26,112

Income statement
  • Gross operating margin +€10,937

    up €10,937 (+88.9%), from €12,308 to €23,245

  • Depreciation +€5,517

    up €5,517 (+64.8%), from €8,512 to €14,030

  • Financial income -€1,519

    down €1,519 (-65.4%), from €2,321 to €802

  • Taxes +€1,164

    up €1,164 (+81.6%), from €1,426 to €2,590

  • Financial charges -€705

    down €705 (-33.6%), from €2,101 to €1,396

Change in the result, 2024 to 2025

effect on the result

For each income-statement line you see the change as its effect on the result. Higher costs lower the result, higher income raises it.

Result 2024 €496
Gross operating margin +€10,937
Staff costs -€152
Depreciation -€5,517
Other operating charges -€12
Financial income -€1,519
Financial charges +€705
Taxes -€1,164
Result 2025 €3,773
raises the resultlowers the result

Derived cash bridge

cash 2024 to 2025

The bridge is derived from the 2024 and 2025 balance sheets and the 2025 result. There is no filed cash-flow statement. You see where the money came from and where it went.

From operations +€6,022
Investment -€1,845
Financing €0
Cash 2024 €38,510
Net result for the year +€3,773
Depreciation +€14,030
Stocks and contracts -€6,126
Receivables within one year +€14,360
Deferred charges and accrued income +€3,646
Trade debts -€10,986
Tax, wage and social debts +€279
Other debts -€12,731
Accrued charges and deferred income -€223
Investment in fixed assets (net) -€1,845
Cash 2025 €42,687
brings cash intakes cash out
Every line side by side 42 lines
Line Code 2024 2025 Change %
Total assets 20/58 €196,687 €176,800 -€19,887 -10.1%
Fixed assets 21/28 €60,917 €48,733 -€12,185 -20.0%
Tangible fixed assets 22/27 €60,917 €48,733 -€12,185 -20.0%
Plant, machinery and equipment 23 €3,877 €4,668 +€791 +20.4%
Furniture and vehicles 24 €56,380 €43,595 -€12,785 -22.7%
Other tangible fixed assets 26 €660 €470 -€190 -28.8%
Current assets 29/58 €135,770 €128,067 -€7,703 -5.7%
Stocks and contracts in progress 3 €53,031 €59,158 +€6,126 +11.6%
Stocks 30/36 €53,031 €59,158 +€6,126 +11.6%
Amounts receivable within one year 40/41 €37,933 €23,573 -€14,360 -37.9%
Trade receivables 40 €33,394 €19,898 -€13,496 -40.4%
Other amounts receivable 41 €4,538 €3,675 -€864 -19.0%
Cash at bank and in hand 54/58 €38,510 €42,687 +€4,177 +10.8%
Deferred charges and accrued income 490/1 €6,295 €2,649 -€3,646 -57.9%
Total equity and liabilities 10/49 €196,687 €176,800 -€19,887 -10.1%
Equity 10/15 €123,954 €127,728 +€3,773 +3.0%
Contributions 10/11 €100,000 €100,000 = 0.0%
Reserves 13 €22,339 €26,112 +€3,773 +16.9%
Distributable reserves 133 €22,339 €26,112 +€3,773 +16.9%
Profit (loss) carried forward 14 €1,615 €1,615 -€0 0.0%
Amounts payable 17/49 €72,733 €49,072 -€23,661 -32.5%
Amounts payable within one year 42/48 €69,645 €46,207 -€23,438 -33.7%
Trade debts 44 €51,749 €40,762 -€10,986 -21.2%
Suppliers 440/4 €51,749 €40,762 -€10,986 -21.2%
Taxes, remuneration and social security 45 €387 €666 +€279 +72.0%
Taxes 450/3 €387 €666 +€279 +72.0%
Other amounts payable 47/48 €17,510 €4,779 -€12,731 -72.7%
Accrued charges and deferred income 492/3 €3,088 €2,865 -€223 -7.2%
Non-recurring operating income 76A - €5,449 +€5,449
Remuneration, social security and pensions 62 €1,707 €1,859 +€152 +8.9%
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets 630 €8,512 €14,030 +€5,517 +64.8%
Other operating charges 640/8 €387 €400 +€12 +3.2%
Gross operating margin 9900 €12,308 €23,245 +€10,937 +88.9%
Operating profit (loss) 9901 €1,702 €6,957 +€5,255 +309%
Financial income 75/76B €2,321 €802 -€1,519 -65.4%
Recurring financial income 75 €2,321 €802 -€1,519 -65.4%
Financial charges 65/66B €2,101 €1,396 -€705 -33.6%
Recurring financial charges 65 €2,101 €1,396 -€705 -33.6%
Profit (loss) for the period before taxes 9903 €1,922 €6,363 +€4,441 +231%
Income taxes 67/77 €1,426 €2,590 +€1,164 +81.6%
Profit (loss) for the period 9904 €496 €3,773 +€3,278 +661%
Profit (loss) for the period to be appropriated 9905 €496 €3,773 +€3,278 +661%
Calculation and sources

Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Green is a favourable move for that line, red an unfavourable one. Prepared on 5 November 2026 via checked.be.